MICA and Miyoshi myopathy: Moreover, in MM cell lines treated with a GSK-3β inhibitor, higher expression levels of MICA were found, which was further augmented in combination with chemotherapeutics, and significantly improved NK cell cytotoxic activity through NKG2D recognition, suggesting that also indirect effects of GSK-3beta therapy can affect NK cell activity [203].